Pressing Pause on Psychedelic Cash

Analysing the Challenges in Psychedelic Drug Development Through Investment Trends

Adrienne Rivlin

Read more

Related Insights

Video / Webinar

Life Sciences & Pharma

Unlocking China's Precision Medicine Potential

August 25, 2025

Life Sciences & Pharma

On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (South Korea)

August 12, 2025

Life Sciences & Pharma

Unlocking the Potential of Next-Generation PROTACs: A Strategic Roadmap for R&D Investment

March 7, 2025

Our client engaged L.E.K. Consulting to develop a market overview across multiple key therapeutic areas (e.g., oncology, immunology, neuroscience) and…

Private Equity

Future Ready: Comprehensive Operational Due Diligence on a Medtech and Life Sciences…

February 24, 2025

A private equity firm approached L.E.K. Consulting to conduct operational due diligence on a promising precision medtech and life sciences engineering…

Executive Insights

Life Sciences & Pharma

Future Outlook for the AOM Market

January 9, 2025

Executive Insights

Life Sciences & Pharma

In Need of an All-Inclusive Trip: Socio-Demographic Diversity in Psychedelic Research

November 15, 2024